Related Experiment Videos
Plasma lipoproteins, cardiovascular reactivity and the sympathetic nervous system
Journal of Autonomic Pharmacology
|August 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation.
Journal of human hypertension·2016
Diuretic use in heart failure and outcomes.
Clinical pharmacology and therapeutics·2013
Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals.
Journal of human hypertension·2013
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes.
Internal medicine journal·2012
Cardio-renal syndrome: new perspective in diagnostics.
Seminars in nephrology·2012
Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: cardioprotection by activation of adenosine A(2A) receptors.
Journal of autonomic pharmacology·2002
Effects of restraint stress on responsiveness of atria and vas deferens in Sprague-Dawley rats.
Journal of autonomic pharmacology·2002
The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro.
Journal of autonomic pharmacology·2002
Adrenaline hypothesis: effect of formoterol on noradrenaline release.
Journal of autonomic pharmacology·2002
The comparison of vitamin C and vitamin E on the protein oxidation of diabetic rats.
Journal of autonomic pharmacology·2002
13N-ammonia positron emission tomography/magnetic resonance imaging in patients with ischemia with non-obstructive coronary arteries: focus on feature tracking and T1 mapping.
Quantitative imaging in medicine and surgery·2026
Nsp1 from divergent coronaviruses has conserved endonuclease activity.
Journal of molecular biology·2026
Mitochondrial proteomic signatures of postcardiac arrest brain injury reveal potential therapeutic targets.
The Journal of pharmacology and experimental therapeutics·2026